Onconetix
ONCO
3 hedge funds and large institutions have $1.73M invested in Onconetix in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
19% less capital invested
Capital invested by funds: $2.13M → $1.73M (-$396K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$200K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$200K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$620K |
| 2 |
Renaissance Technologies
New York
|
-$25K |
| 3 |
Millennium Management
New York
|
-$20K |
| 4 |
Two Sigma Investments
New York
|
-$19.6K |
| 5 |
VF
Virtu Financial
New York
|
-$18K |
ONCO Hedge Fund Activity: Q1 2023 in Review
3 of the 6,282 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q1 2023, worth a combined $1.73M — down 19% from $2.13M a quarter earlier.
Fund positioning in ONCO was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Cetera Advisor Networks, adding an estimated $200K. The largest seller was Sabby Management, exiting entirely with an estimated $620K sold.
- 3 institutional investors held Onconetix (ONCO) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $1.73M of Onconetix stock for Q1 2023, down 19% quarter-over-quarter.
- 1 fund opened new Onconetix positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest Onconetix buyer in Q1 2023 was Cetera Advisor Networks, an estimated $200K added.
- The largest Onconetix seller in Q1 2023 was Sabby Management, an estimated $620K sold.
Based on aggregated 13F filings for Q1 2023.